Prognosis and adjuvant chemotherapy for patients with malignant peritoneal cytology in early-stage non-endometrioid endometrial cancer
Authors:
Open Access
- 10 September 2023
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 49 (11) , 107071
Abstract
No abstract availableKeywords
All Related Versions
This publication has 19 references indexed in Scilit:
- Clinical calculator predictive of chemotherapy benefit in stage 1A uterine papillary serous cancersGynecologic Oncology, 2020
- Omental Micrometastasis in Endometrial CancerOncology Research and Treatment, 2019
- Significance of abnormal peritoneal cytology on survival of women with stage I–II endometrioid endometrial cancerGynecologic Oncology, 2018
- The role of adjuvant therapy in stage IA serous and clear cell uterine cancer: A multi-institutional pooled analysisGynecologic Oncology, 2018
- Prognosis and treatment of positive peritoneal cytology in early endometrial cancer: matched cohort analyses from the National Cancer DatabaseAmerican Journal of Obstetrics and Gynecology, 2018
- Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapyJournal of Gynecologic Oncology, 2018
- Is Omentectomy Necessary for Non-Endometrioid Endometrial CancerGynecologic and Obstetric Investigation, 2017
- Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studiesStatistics in Medicine, 2015
- Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/Gynecologic Oncology Group 210 TrialJNCI: Journal of the National Cancer Institute, 2015
- Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancerGynecologic Oncology, 2013